The Solomon Partners Healthcare group provides best-in-class M&A and capital advisory services to publicly traded, privately held, and financial sponsor clients across the healthcare landscape. We combine deep industry expertise with proven execution capabilities and a high level of service to deliver superior results to clients across our core coverage areas, which include:
Our senior team experience includes some of the most notable healthcare M&A transactions in the past two decades, with a combined transaction value of over $200 billion. The core tenets of our franchise include:
Served as financial advisor to Lantheus on the sale of its SPECT business to SHINE Technologies
Served as financial advisor to Niowave on its non-dilutive financing
Served as financial advisor to Advent International on its acquisition of PatientPoint
Served as financial advisor to PharmaLogic, a portfolio company of Webster Equity Partners and MedEquity Capital, on its acquisition of Agilera Pharma AS
Served as financial advisor to GetixHealth, a portfolio company of H.I.G. Capital, on its acquisition of Americollect
Served as financial advisor to Lantheus on its acquisition of Evergreen Theragnostics, with an upfront value of $275M and total value of up to $1B
Served as financial advisor to Willow Innovations on its acquisition of Elvie
Served as financial advisor to Guerbet on the sale of its Accurate Medical microcatheter assets to Argon Medical
Served as financial advisor to GE HealthCare on its acquisition of the remaining 50% stake in Nihon Medi-Physics
Served as financial advisor to Platinum Equity on its acquisition of ASP Global
Served as financial advisor to SOFIE Biosciences on its growth investment from Trilantic North America
Served as financial advisor to Prime Therapeutics on its strategic alliance with and minority investment in Capital Rx
Subscribe Episode Description In this episode of Solomon Connects , Solomon Partners’ Head of Healthcare Jon Hammack joins M&A Director Chris Moynihan to unpack the current state of the healthcare M&A market and the key themes shaping a more constructive deal environment this year. Jon shares insights on sponsor and strategic dynamics, record pipelines, improving…
Last month, industry leaders convened in San Francisco for the 44 th annual J.P. Morgan Healthcare Conference. Jon Hammack , Head of Healthcare at Solomon Partners, shared his views on where momentum is building—as well as the challenges remaining—in healthcare M&A heading into 2026. Hammack’s top insights include: 1. M&A Momentum Is Improving—But the Real…
Subscribe Episode Description This cross‑industry roundtable from Solomon Partners examines how the M&A landscape evolved in 2025 and the factors expected to shape deal activity in 2026 across healthcare, technology, and financial services. Industry coverage bankers Jon Pritti , James Butcher , and Alex DeOteris join M&A Director Chris Moynihan to discuss key macro and…
